logo
Sign In
  1. Home
  2. Indications
  3. Intraocular Lens Associated Postoperative Inflammation

Medications for Intraocular Lens Associated Postoperative Inflammation

FiltersReset Filters
5 results

  • bromsite

    (bromfenac)
    Medication Details
    Sun Pharmaceutical Industries, Inc.
    Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
    Medication Details
    Drug Interactions

  • dexycu

    (dexamethasone)
    Medication Details
    EyePoint Pharmaceuticals US, Inc
    Usage: DEXYCU (dexamethasone intraocular suspension) 9% is indicated for the treatment of postoperative inflammation following eye surgery.
    Medication Details
    Drug Interactions

  • ketorolac tromethamine

    (ketorolac tromethamine)
    Medication Details
    SOLA Pharmaceuticals, LLC
    Usage: Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching caused by seasonal allergic conjunctivitis and for treating postoperative inflammation in patients who have undergone cataract extraction.
    Medication Details
    Drug Interactions

  • ketorolac tromethamine

    (ketorolac tromethamine)
    Medication Details
    Sandoz Inc
    Usage: Ketorolac tromethamine ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.
    Medication Details
    Drug Interactions

  • prolensa

    (Bromfenac Sodium)
    Medication Details
    Bausch & Lomb Incorporated
    Usage: PROLENSA® (bromfenac ophthalmic solution) 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.